| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/17/1995 | US5382657 Peg-interferon conjugates |
| 01/17/1995 | US5382601 Memantine-containing solid pharmaceutical dosage forms having an extended two-stage release profile and production thereof |
| 01/17/1995 | US5382590 N-phenyl-N-acetamidoglycinamides, their preparation and medicaments containing them |
| 01/17/1995 | US5382574 Diabetes |
| 01/17/1995 | US5382569 Hexapeptides for cardiovascular disorders |
| 01/17/1995 | US5382568 Regulating release of prolactin and luteinizing hormone |
| 01/17/1995 | US5382524 Cloning and expression of biologically active α-n-acetylgalactosaminidase |
| 01/17/1995 | US5382509 Method and kit for the diagnosis of human papillomavirus type 41 |
| 01/17/1995 | US5382435 Microparticulate pharmaceutical delivery system |
| 01/17/1995 | US5382431 Administering a heat stable peptone digest complexed with an ionic transition metal to accelerate healing of topical wounds in mammals |
| 01/17/1995 | US5382427 Use of IL-4 to treat solid tumors |
| 01/17/1995 | CA2128175A1 Determination of lymph nodes enriched in tumor reactive cells, their proliferation, and their use in adoptive cellular therapy |
| 01/17/1995 | CA2128160A1 Cation-complexed polysaccharides |
| 01/16/1995 | CA2127897A1 Bifunctional variants of urokinase with improved fibrinolytic properties and thrombin-inhibiting activity |
| 01/12/1995 | WO1995001568A1 Immunoassay for soluble fibrin polymers |
| 01/12/1995 | WO1995001457A1 Htlv-iinra compositions and assays for detecting htlv infection |
| 01/12/1995 | WO1995001436A1 Conotoxins having acetylcholin receptor binding properties |
| 01/12/1995 | WO1995001434A1 A truncated keratinocyte growth factor (kgf) having increased biological activity |
| 01/12/1995 | WO1995001433A1 Protein s deletion variants deficient in c4bp binding activity, but having apc cofactor activity, compositions and therapeutic methods |
| 01/12/1995 | WO1995001431A1 Peptide family, designated as xenonins |
| 01/12/1995 | WO1995001429A1 Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases |
| 01/12/1995 | WO1995001428A1 Glycosylated and non-glycosylated bactericidal/permeability increasing proteins, and methods for producing same |
| 01/12/1995 | WO1995001427A1 Pro-urokinase mutants |
| 01/12/1995 | WO1995001425A1 Compositions comprising protein disulfide redox agents |
| 01/12/1995 | WO1995001424A1 Transformed mammalian cells capable of expressing cecropin b |
| 01/12/1995 | WO1995001420A2 A method of producing a protein disulfide redox agent |
| 01/12/1995 | WO1995001376A1 Peptide inhibitors of mitogenesis and motogenesis |
| 01/12/1995 | WO1995001375A1 Inhibitor of collagen-stimulated platelet aggregation |
| 01/12/1995 | WO1995001374A1 Synthetic peptides of human papillomavirus |
| 01/12/1995 | WO1995001373A1 Process for manufacture of 1-deamino-8-d-arginine vasopressin |
| 01/12/1995 | WO1995001372A1 Peptidase resistant thrombin receptor peptide ligand |
| 01/12/1995 | WO1995001371A1 Novel peptide and antiplatelet aggregation containing the same |
| 01/12/1995 | WO1995001370A1 Higher order structure and binding of peptide nucleic acids |
| 01/12/1995 | WO1995001369A1 Double-stranded peptide nucleic acids |
| 01/12/1995 | WO1995001368A1 Improved synthesis of cyclic peptides |
| 01/12/1995 | WO1995001353A1 Antihypertensive tricyclic azepine derivatives useful as inhibitors of enkephalinase and ace |
| 01/12/1995 | WO1995001188A1 Polyvalent peptide pharmaceutical applications |
| 01/12/1995 | WO1995001185A1 Stabilized pharmaceutical peptide compositions |
| 01/12/1995 | WO1995001183A1 Compositions for nasal administration of desmopressin |
| 01/12/1995 | WO1995001182A1 THF-η2 ANALOGS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM |
| 01/12/1995 | WO1995001163A1 Novel pharmaceutical peptide preparations for general delivery |
| 01/12/1995 | WO1995001155A1 Oral compositions |
| 01/12/1995 | WO1995001131A1 Method of regenerating articular cartilage |
| 01/12/1995 | WO1995001096A1 Pharmaceutical compositions and use thereof for treatment of neurological diseases and etiologically related symptomology |
| 01/12/1995 | WO1995001095A1 Transformed eukaryotic cells, and transposon-based transformation vectors |
| 01/12/1995 | WO1994018326A3 Regulatory gene for clavulanic acid biosynthesis |
| 01/12/1995 | DE4321965A1 Oxytocin-containing composition and the use thereof as remedy, in particular nasal spray for the treatment of sexual dysfunctions |
| 01/12/1995 | CA2166488A1 Glycosylated and non-glycosylated bactericidal/permeability increasing proteins, and methods for producing same |
| 01/12/1995 | CA2166462A1 Double-stranded peptide nucleic acids |
| 01/12/1995 | CA2166461A1 Higher order structure and binding of peptide nucleic acids |
| 01/12/1995 | CA2166386A1 Immunoassay for soluble fibrin polymers |
| 01/12/1995 | CA2166383A1 Pharmaceutical compositions and use thereof for treatment of neurological diseases and etiologically related symptomology |
| 01/12/1995 | CA2166333A1 Synthetic peptides of human papillomavirus |
| 01/12/1995 | CA2166298A1 Peptide family, designated as xenonins |
| 01/12/1995 | CA2166278A1 A truncated keratinocyte growth factor (kgf) having increased biological activity |
| 01/12/1995 | CA2165977A1 Pro-urokinase mutants |
| 01/12/1995 | CA2142713A1 Peptide inhibitors of mitogenesis and motogenesis |
| 01/11/1995 | EP0633318A1 Transduced fibroblasts and uses therefor |
| 01/11/1995 | EP0633313A1 Vaccine against lyme disease |
| 01/11/1995 | EP0633029A2 Further improvements relating to drug delivery systems |
| 01/11/1995 | EP0633028A1 Vaccine against lyme disease |
| 01/11/1995 | EP0632834A1 Microorganisms having attenuated invasiveness |
| 01/11/1995 | EP0632833A1 Compositions and methods for pace 4 and 4.1 gene and polypeptides in cells |
| 01/11/1995 | EP0632832A1 Protein kinases |
| 01/11/1995 | EP0632829A1 Thrombin receptor antagonists |
| 01/11/1995 | EP0632820A1 High concentration homogenized collagen compositions |
| 01/11/1995 | EP0632817A1 Neurotrophic factors having altered receptor binding specificities |
| 01/11/1995 | EP0632727A1 Conjugates formed from heat shock proteins and oligo- or polysaccharides |
| 01/11/1995 | EP0632726A1 A method for treating kaposi's sarcoma and blocking or inhibiting vascular permeability |
| 01/11/1995 | EP0632722A1 A dna transporter system and method of use |
| 01/11/1995 | EP0605428A4 Hormone-secreting cells maintained in long-term culture. |
| 01/11/1995 | CN1097192A Retroviral protease inhibitors |
| 01/11/1995 | CN1097125A Medicinal composite for treating postoperative syndrome of gallbladder |
| 01/11/1995 | CN1097124A Formulations containing unsaturated fatty acids |
| 01/11/1995 | CN1027346C Wound healing and bone regeneration composition |
| 01/10/1995 | US5380927 Process for preparing optically active 2-aryl-alkanoic acids, in particular 2-aryl-propionic acids |
| 01/10/1995 | US5380925 Cyclic amino acids and derivatives thereof |
| 01/10/1995 | US5380921 Aminophosponic acid derivative |
| 01/10/1995 | US5380836 Nucleic acid encoding sodium channel protein |
| 01/10/1995 | US5380830 Molecular clones of bovine immunodeficiency-like virus |
| 01/10/1995 | US5380824 One-step, one-container method for the preparation of pyridoxylated hemoglobin |
| 01/10/1995 | US5380758 Respiratory, gastrointestinal |
| 01/10/1995 | US5380745 Medicinal composition |
| 01/10/1995 | US5380727 Synergistic combination for treating herpes infections |
| 01/10/1995 | US5380713 Serine protease inhibitors |
| 01/10/1995 | US5380712 Truncated human serum albumin polypeptides as plasma expanding agents |
| 01/10/1995 | US5380710 Pharmaceutical compositions containing ACTH (1-24) for the therapy of shock conditions and respiratory and cardiocirculatory insufficiences |
| 01/10/1995 | US5380656 Chymopapain and method of purifying it on an inhibitory dipeptide affinity column |
| 01/10/1995 | US5380655 Forming transformed Haemophilus influenzae cells used to make Haemophilus P2 antigen by transforming Haemophilus host cells with recombinant vector including DNA sequence encoding the antigen; selecting transformants expressing antigen; vector |
| 01/10/1995 | US5380648 Method for the diagnosis of virulent bacteria |
| 01/10/1995 | US5380531 C-terminal substituted |
| 01/10/1995 | US5380513 Methods for reducing non-target retention of immunoconjugates and metabolites thereof |
| 01/10/1995 | CA1333892C Insulin-selective somatostatin analogs |
| 01/05/1995 | WO1995000850A1 A novel family of pollen proteinases, methods of use thereof and compositions derived therefrom |
| 01/05/1995 | WO1995000848A1 Compositions and methods for anti-addictive narcotic analgesis acivity screening and treatments |
| 01/05/1995 | WO1995000846A1 Domain ligation strategy to engineer proteins with unusual architectures |
| 01/05/1995 | WO1995000659A1 Monoclonal antibodies against the alpha pdgf receptor and uses thereof |
| 01/05/1995 | WO1995000657A1 Anti-sickling hemoglobin |
| 01/05/1995 | WO1995000654A1 Mesothelial cell gene therapy |
| 01/05/1995 | WO1995000651A1 Recombinant stratum corneum chymotryptic enzyme (scce) |